Biofrontera Inc
Change company Symbol lookup
Select an option...
BFRI Biofrontera Inc
IGC India Globalization Capital Inc
KSM DWS Strategic Municipal Income Trust
CNC Centene Corp
WPM Wheaton Precious Metals Corp
HPX^ HPX Corp
KRNLU Kernel Group Holdings Inc
$TFRRU1000GCADL Russell 1000 Growth CAD Total Return
AOUT American Outdoor Brands Inc
BDC Belden Inc
Go

Company profile

Biofrontera Inc is a biopharmaceutical company. The Company is specialized in the commercialization of pharmaceutical products for the treatment of dermatological conditions for the diseases caused primarily by exposure to sunlight that result in sun damage to the skin. Its products focus on the treatment of actinic keratoses, which are skin lesions that lead to skin cancer. It also markets a topical antibiotic for treatment of impetigo, a bacterial skin infection. The Company’s principal product is Ameluz, which is a prescription drug for use in combination with its medical device, the BF-RhodoLED lamp, for photodynamic therapy (PDT) in the United States for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It offers Xepi for the treatment of impetigo, a common skin infection, due to Staphylococcus aureus or streptococcus pyogenes.

Price
Delayed
$5.56
Day's Change
1.23 (28.41%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.58
Day's Low
4.23
Volume
(Heavy Day)

Today's volume of 59,754,619 shares is on pace to be much greater than BFRI's 10-day average volume of 42,029,659 shares.

59,754,619

Display:

Providers:

UpdateCancel
6 providers
Today's News, December 02, 2021
Biofrontera Inc. Announces Notice of Allowance for U.S. Patent on Innovative Illumination Protocol

Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the U.S...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.